Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-10-23
1998-08-04
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546201, A61K 31445, C07D40112
Patent
active
057894213
ABSTRACT:
A fibrinogen receptor antagonist which is a.-alanine.
REFERENCES:
patent: 4064255 (1977-12-01), Champseix et al.
patent: 4122255 (1978-10-01), Krapcho
patent: 4243807 (1981-01-01), Friebe et al.
patent: 4622331 (1986-11-01), Jozic
patent: 5030654 (1991-07-01), Barnish et al.
patent: 5064814 (1991-11-01), Klein et al.
patent: 5227490 (1993-07-01), Hartman et al.
patent: 5559127 (1996-09-01), Hartman
Ford-Hutchinson AW et al. Can. J. Physiol. Pharmacol. 67, 989-993, 1989.
Halczenko Wasyl
Hutchinson John H.
Huang Evelyn
Merck & Co. , Inc.
Parr Richard S.
Rotman Alan L.
Winokur Melvin
LandOfFree
Fibrinogen receptor antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrinogen receptor antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinogen receptor antagonist will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1177516